J. Koshio

发表

Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy

I. Narita, K. Nakata, Daisuke Ishikawa, 2015, The Journal of Immunology.

Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC

Daisuke Ishikawa, Hiroshi Tanaka, Kosuke Ichikawa, 2022, Scientific reports.

immunity during recovery from lymphopenia Depletion of radio-resistant regulatory T cells enhances antitumor

I. Narita, K. Nakata, Hiroshi Tanaka, 2013 .

Recurrent Interstitial Lung Disease Induced By Various Therapies forNon-Small Cell Lung Cancer

I. Narita, Hiroshi Tanaka, H. Kagamu, 2014 .

Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy

I. Narita, K. Nakata, Daisuke Ishikawa, 2015, The Journal of Immunology.

after Lymphodepleting Chemotherapy Regulatory T Cells in Antitumor Immunity Critical Roles of Chemoresistant Effector and

K. Nakata, Daisuke Ishikawa, Kosuke Ichikawa, 2015 .

$$K^{*}(892)^0$$ meson production in inelastic p+p interactions at 40 and 80 $$\text{ GeV }\!/\!c$$ beam momenta measured by NA61/SHINE at the CERN SPS

A. Blondel, A. Matyja, W. Dominik, 2021, The European Physical Journal C.

Epitope diversification driven by non-tumor epitope-specific Th1 and Th17 mediates potent antitumor reactivity.

I. Narita, Kosuke Ichikawa, H. Kagamu, 2012, Vaccine.

Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC

Daisuke Ishikawa, Hiroshi Tanaka, Kosuke Ichikawa, 2021, Scientific reports.

Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501)

K. Nishio, Daisuke Ishikawa, T. Sekiya, 2022, Cancers.

$$K^{*}(892)^0$$ meson production in inelastic p+p interactions at 40 and 80 $$\text{ GeV }\!/\!c$$ beam momenta measured by NA61/SHINE at the CERN SPS

W. Kucewicz, A. Blondel, A. Matyja, 2021, The European Physical Journal C.

Panniculitis as the initial manifestation of dermatomyositis with anti‐MDA5 antibody

R. Abe, Y. Shimomura, J. Koshio, 2017, Clinical and experimental dermatology.

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

Rie Kondo, Junko Baba, Hiroshi Kagamu, 2011, BMC Cancer.

Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia.

I. Narita, K. Nakata, Hiroshi Tanaka, 2012, Blood.

DEAD/H (Asp–Glu–Ala–Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cells

I. Narita, H. Kagamu, Satoshi Watanabe, 2013, Cancer Immunology, Immunotherapy.

Vaccination with CD133+ melanoma induces specific Th17 and Th1 cell–mediated antitumor reactivity against parental tumor

I. Narita, K. Nakata, Hiroshi Tanaka, 2011, Cancer Immunology, Immunotherapy.

Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients

Aya Ohtsubo, Kosuke Ichikawa, T. Kikuchi, 2021, Translational lung cancer research.

Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia.

I. Narita, K. Nakata, Hiroshi Tanaka, 2012, Blood.